Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Can AstraZeneca Sustain Its Pipeline-Driven Growth Story?

AstraZeneca PLC (LSE: AZN)is a global biopharmaceutical company, researching, developing, manufacturing, and commercialising prescription medicines across oncology, rare disease, cardiovascular, respiratory, and other therapeutic areas.

Ishan Mudgal | 10 July 2026

Genflow Biosciences Shares Decline: Why Is GENF Stock in Focus?

• GENF shares declined 3.75% on 10 July 2026, closing at 1.93 GBX.• Genflow Biosciences PLC has a market capitalization of approximately 11.33 million GBP, placing it in the micro-cap segment.• The company focuses on longevity biotechnology and developing therapies targeting age-related conditions.• Research …

Ankur Sharma | 10 July 2026

Can Genus plc Continue Leading Innovation in Animal Genetics?

Investors continue to monitor demand trends within key markets, including China, where pork production economics and disease pressures such as African swine fever have historically influenced demand for genetic products.

Divya Sood | 10 July 2026

Sareum Holdings Shares Rise: Why Are Investors Watching SAR Stock?

• SAR shares gained 3.87% on 10 July 2026, closing at 23.89 GBX.• Sareum Holdings PLC has a market capitalization of approximately 31.87 million GBP, placing it in the micro-cap segment.• The company is a clinical-stage biotechnology business focused on developing therapies for autoimmune …

Ankur Sharma | 10 July 2026

EDX Medical Shares Surge: What's Driving Investor Interest in EDX Stock?

• EDX shares gained 7.69% on 10 July 2026, closing at 10.50 GBX.• EDX Medical Group PLC has a market capitalization of approximately 40.17 million GBP, placing it in the small-cap segment.• The company develops diagnostic testing solutions and healthcare technologies for disease detection …

Ankur Sharma | 10 July 2026

Can Shield Therapeutics Scale Global Sales of Its Iron Deficiency Treatment?

Shield Therapeutics Plc (AIM: STX)Shield Therapeutics plc is a commercial-stage specialty pharmaceutical company that develops and markets Feraccru/Accrufer, an oral treatment for iron deficiency, through direct sales and partnering arrangements in various markets.

Ishan Mudgal | 09 July 2026

Can Poolbeg Pharma Turn Its Infectious Disease Pipeline Into Its Next Value Catalyst?

Poolbeg Pharma PLC (AIM: POLB)Poolbeg Pharma plc is a UK biopharmaceutical company focused on developing treatments for infectious diseases, using a capital-efficient model that advances assets through early clinical development before seeking partnering or licensing opportunities.

Ishan Mudgal | 09 July 2026

Can Tristel Expand Its Global Footprint in Infection Prevention?

Tristel Plc (AIM: TSTL)Tristel plc develops and manufactures infection prevention and decontamination products, based on chlorine dioxide technology, used primarily for high-level disinfection of medical devices in healthcare settings.

Ishan Mudgal | 09 July 2026

Spire Healthcare Shares Edge Higher: Why Are Investors Watching SPI Stock?

• SPI shares gained 0.95% on 9 July 2026, closing at 213.50 GBX.• Spire Healthcare Group PLC has a market capitalization of approximately 851.84 million GBP.• The company operates a network of private hospitals and healthcare facilities providing medical treatments and specialist services.• Healthcare …

Ankur Sharma | 09 July 2026

PureTech Health Shares Edge Higher: Why Are Investors Watching PRTC Stock?

• PRTC shares gained 0.51% on 9 July 2026, closing at 118.80 GBX.• PureTech Health PLC has a market capitalization of approximately 287.72 million GBP, placing it in the small-cap healthcare segment.• The company develops biotechnology businesses and advances therapeutic programmes through its research …

Ankur Sharma | 09 July 2026
Support

Hi! How can we help you today?

Loading…